eFFECTOR Therapeutics Inc...
0.00
null (null%)
At close: Jan 14, 2025, 8:00 PM

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19
Revenue n/a 3.55M 1.43M 42.00M n/a
Cost of Revenue 111.00K 53.00K 24.00K 21.83M 307.00K
Gross Profit -22.92M 3.50M 1.41M 20.17M -307.00K
Operating Income -33.84M -32.40M -31.90M 15.82M -28.61M
Interest Income 1.95M 439.00K 6.00K 67.00K 239.00K
Pretax Income -35.81M -22.66M 15.80M 14.56M -29.74M
Net Income -35.81M -12.93M 15.80M 14.21M -29.74M
Selling & General & Admin 10.93M 12.64M 13.37M 4.35M 4.71M
Research & Development 22.92M 23.31M 19.96M 21.83M 23.58M
Other Expenses n/a -3.55M -1.43M 9.00K n/a
Operating Expenses 33.84M 32.40M 31.90M 26.18M 28.30M
Interest Expense n/a 2.25M 1.76M 1.33M 1.38M
Selling & Marketing Expenses n/a n/a n/a n/a n/a
Cost & Expenses 33.84M 32.40M 31.90M 26.18M 28.61M
Income Tax n/a -9.74M -24.00K 351.00K 135.14K
Shares Outstanding (Basic) 2.19M 1.65M 1.62M 598.56K 552.43K
Shares Outstanding (Diluted) 2.19M 1.65M 1.62M 598.56K 552.43K
EPS (Basic) -16.37 -7.85 9.78 23.74 -53.83
EPS (Diluted) -16.37 -7.85 9.78 23.74 -53.83
EBITDA -33.73M -32.40M -31.90M 16.05M -28.30M
Depreciation & Amortization 111.00K 53.00K 24.00K 160.00K 307.00K